05.24.10
ICON has acquired Timaq Medical Imaging, a provider of imaging services to pharma/biopharma firms, based in Zurich, Switzerland.
“The acquisition of Timaq will complement our existing U.S. operations by giving ICON a European base for our Medical Imaging operations,” commented Ted Gastineau, president of ICON Medical Imaging. “Alongside the immediate access to an experienced imaging team, Timaq’s strong links to leading medical institutions gives us access to important scientific expertise in the imaging field that will bring significant benefits to our clients.”
“We are excited to be joining ICON,” commented Gustav von Schulthess, co-founder of Timaq. “Together we can enhance and expand the range of imaging services we offer our clients, while ICON’s global footprint will enable us to support even the largest multi-country imaging studies. We look forward to working closely with ICON’s imaging team to continue providing innovative imaging solutions that can help expedite clients’ drug development projects.”
“The acquisition of Timaq will complement our existing U.S. operations by giving ICON a European base for our Medical Imaging operations,” commented Ted Gastineau, president of ICON Medical Imaging. “Alongside the immediate access to an experienced imaging team, Timaq’s strong links to leading medical institutions gives us access to important scientific expertise in the imaging field that will bring significant benefits to our clients.”
“We are excited to be joining ICON,” commented Gustav von Schulthess, co-founder of Timaq. “Together we can enhance and expand the range of imaging services we offer our clients, while ICON’s global footprint will enable us to support even the largest multi-country imaging studies. We look forward to working closely with ICON’s imaging team to continue providing innovative imaging solutions that can help expedite clients’ drug development projects.”